While the Czech parliament discusses the amendment to the Criminal Code that would effectively decriminalise drug use, the Constitutional Court has repealed part of the law concerning small amounts of cannabis and ‘magic’ mushrooms.

What can we learn from the failures of repressive drug laws? How can we convince the people that they are failed? What are the alternatives of punitive drug policies? A group of NGOs launched a campaign to mark the 50th anniversary of the Misuse of Drugs Act in the UK – and the 100th anniversary of the drug law in Belgium. We discuss lessons learnt with Ester Kincova from Transform and Stéphane Leclercq from Fedito Brussels.

The Norwegian government presented its plan to decriminalise drug use last week – read this report from Arild Knutsen, a leading drug user activist.

his is the first episode of Drugreporter News, our monthly news update from the world of drug policy, with Orsolya Fehér.

Recent large drug seizures and arrests don’t show that so-called drug supply reduction works. The system is broken but we don’t dare to ask the right questions. 

In Italy, the documentary film on the San Patrignano community has started a wide debate on drugs. Please read the passionate article of Susanna Ronconi (Forum Droghe) on the culture of silence and lies that contributed to the torture and abuse of people who use drugs!

Sanpa, a new miniseries now featured on Netflix, tells the story about how a man’s dream of saving people from addiction turned into a nightmare.

Youth Organisations for Drug Action (YODA) is a European network that brings together organisations at the forefront of harm reduction and drug policy reform.

The new opinion paper adopted by the European Economic and Social Committee (EESC) calls for less law enforcement and more health and human rights in the new EU Drugs Strategy.

The thematic working group on civil society involvement of the Civil Society Forum on Drugs, an expert group of the EU Commission, conducted this review of literature on meaningful civil society involvement in the field of drug policy.